GNECCHI, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 5.815
AS - Asia 4.499
EU - Europa 3.514
SA - Sud America 613
AF - Africa 181
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.642
Nazione #
US - Stati Uniti d'America 5.658
CN - Cina 1.993
SG - Singapore 1.065
IE - Irlanda 824
IT - Italia 500
HK - Hong Kong 488
BR - Brasile 466
DE - Germania 434
RU - Federazione Russa 431
VN - Vietnam 401
FI - Finlandia 377
UA - Ucraina 237
FR - Francia 206
GB - Regno Unito 139
IN - India 132
SE - Svezia 121
ZA - Sudafrica 109
CA - Canada 88
BD - Bangladesh 62
JP - Giappone 56
AR - Argentina 53
MX - Messico 50
AT - Austria 47
TR - Turchia 40
PL - Polonia 38
ID - Indonesia 37
BE - Belgio 33
NL - Olanda 33
IQ - Iraq 30
ES - Italia 27
EC - Ecuador 25
MY - Malesia 22
PH - Filippine 21
CO - Colombia 19
PK - Pakistan 19
SA - Arabia Saudita 18
VE - Venezuela 17
KE - Kenya 16
AE - Emirati Arabi Uniti 15
JO - Giordania 14
UZ - Uzbekistan 12
LT - Lituania 11
MA - Marocco 11
MU - Mauritius 11
AU - Australia 9
CL - Cile 9
AL - Albania 8
CH - Svizzera 8
EG - Egitto 8
PE - Perù 8
PY - Paraguay 8
TN - Tunisia 8
AZ - Azerbaigian 6
BO - Bolivia 6
CZ - Repubblica Ceca 6
IL - Israele 6
IR - Iran 6
KR - Corea 6
NP - Nepal 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EU - Europa 5
KG - Kirghizistan 5
PT - Portogallo 5
SN - Senegal 5
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
PA - Panama 4
AO - Angola 3
BY - Bielorussia 3
CM - Camerun 3
CR - Costa Rica 3
HR - Croazia 3
JM - Giamaica 3
KW - Kuwait 3
PS - Palestinian Territory 3
RO - Romania 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
GI - Gibilterra 2
LV - Lettonia 2
MK - Macedonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TW - Taiwan 2
BB - Barbados 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 14.628
Città #
Dublin 824
Chandler 686
San Jose 658
Singapore 587
Ashburn 545
Hong Kong 475
Beijing 424
Dallas 416
Nanjing 363
Jacksonville 319
New York 203
Boardman 200
Helsinki 166
Los Angeles 164
Wilmington 147
Princeton 145
Ho Chi Minh City 136
Lauterbourg 136
Lawrence 134
Nanchang 132
Munich 122
Hanoi 104
Changsha 103
Hebei 103
Pavia 101
Johannesburg 96
Shenyang 95
Medford 92
Jiaxing 86
Shanghai 86
Ann Arbor 76
Moscow 76
Hangzhou 71
Buffalo 66
São Paulo 55
Redondo Beach 54
Nuremberg 53
Milan 51
Tokyo 49
Council Bluffs 48
Orem 45
Tianjin 45
Turku 43
Santa Clara 39
Toronto 39
Frankfurt am Main 35
Warsaw 34
Brussels 28
Woodbridge 28
Chennai 27
Montreal 26
Denver 25
The Dalles 25
Brooklyn 24
Norwalk 23
Dearborn 22
Falls Church 22
Guangzhou 21
London 20
Rome 20
Seattle 20
Fairfield 19
Atlanta 18
Boston 18
Falkenstein 18
Mexico City 18
Rio de Janeiro 18
Verona 18
Vienna 18
Belo Horizonte 17
Da Nang 17
Haiphong 17
Mumbai 16
Washington 16
Amsterdam 15
Chicago 15
Piscataway 15
Nairobi 14
Ankara 13
Columbus 13
Houston 13
San Francisco 13
Zhengzhou 13
Amman 12
Baghdad 12
Manchester 12
Poplar 12
Stockholm 12
Phoenix 11
Caracas 10
Chieti 10
Jakarta 10
New Delhi 10
Quito 10
Redwood City 10
Tashkent 10
Des Moines 9
Kunming 9
Lahore 9
Brasília 8
Totale 9.586
Nome #
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 251
Cellule staminali mesenchimali fetali isolate da placenta esercitano effetti paracrini cardioprotettivi. 205
Allogeneic Lethally Irradiated Cord Blood Mononuclear Cells in No-Option Critical Limb Ischemia: A “Box of Rain” 167
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 160
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 153
Concomitant overexpression of IGF1 and BMP2 in mesenchymal stem cells mediates cytoprotection through both autocrine and paracrine activation of Akt, Erk1/2 and SMAD1/5/8 pathways. 151
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain 133
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 133
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 131
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 131
Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 130
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 129
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 129
Combined transcriptomic and proteomic approach identifies several putative paracrine factors of fetal mesenchymal stem cells. 127
Improved transduction efficiency of human amniotic mesenchymal stem cells using optimized lentiviral vectors 127
Paracrine mechanisms of mesenchymal stem cells in tissue repair 124
Adult stem cell-based therapy for the heart 123
Novel experimental protocol to study area at risk, infarct size, immunohistochemistry and tissue protein content on the same rodent heart. 123
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 122
Mesenchymal stem cell therapy for heart disease. 122
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 121
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 120
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 119
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 119
Donor Age Negatively Influences Cytoprotective but Not Proangiogenic Paracrine Properties of Human Mesenchymal Stem Cells. 119
Identificazione di fattori paracrini e cardioprotettivi mediante analisi combinata del trascrittoma e del proteoma di cellule staminali mesenchimali fetali. 118
Human fetal mesenchymal stem cells protect cardiac myocytes against hypoxia/reoxygenation injury 117
Identification of cardioprotective factors produced by fetal mesenchymal stem cells through a combined transcriptomic and proteomic approach. 116
Testing the paracrine properties of human mesenchymal stem cells using conditioned medium 116
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 115
Impiego di cellule staminali mesenchimali in cardiologia. 115
Studio pilota sull'impiego di cellule CD133+ immunoselezionate per il trattamento di vasculopatie periferiche. 114
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 114
Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 113
Enhancing the cardiomyogenic potential of human mesenchymal stem cells by modulation of miR expression. 113
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 113
Cord blood derived endothelial progenitor cells: time dependent in vitro generation capacity. 112
Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages 112
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 112
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 112
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 112
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 111
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 111
Gene and cell-based therapies for heart disease 109
Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta 109
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 109
L'età influenza negativamente gli effetti paracrini caridoprotettivi mediati da cellule staminali mesenchimali. 108
Cord blood derived endothelial progenitor cells: a superior buiding company in angiogenesis market. 108
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 108
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 108
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 107
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 107
IRES-based lentivirus co-espressing TGFbeta1 and FGF2 improves cell survival and angiogenesis in bone marrow-derived mesenchymal stem cells. 106
MicroRNA133 and microRNA499 exert synergistic effect on cardiac differentiation 106
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 106
Enhancing stem cell therapy efficacy through genetic modification 105
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 105
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 105
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 104
microRNA and Cardiac Regeneration 103
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 103
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 102
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 102
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. 102
First-in-man case of non-invasive proton radiotherapy for the treatment of refractory ventricular tachycardia in advanced heart failure 101
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 101
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction 101
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'? 101
La contemporanea overespressione di miRNA499 e miRNA133 induce il differenziamento in senso cardiomiocitario di cellule staminali pluripotenti. 100
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 100
Cord blood-derived endothelial progenitor cells: a superior building company in the angiogenesis market: P599 100
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 99
Leptin affects the inflammatory response after STEMI 99
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 99
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 98
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 98
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell mediated cardiac repair and functional improvement 97
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 97
Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction and conditioned media production 96
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 96
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 96
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 94
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries 93
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells 93
Mesenchymal stem cell therapy for heart disease. 92
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 92
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 91
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 91
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future 90
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes 90
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 88
The prognostic value of serial troponin measurements in patients admitted for COVID-19 88
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 86
the procardiomyogenic effect of miR499 is sinergistically enhanced by miR133. 85
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias 85
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 85
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart 85
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 83
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 83
Cytokine-mobilized bone marrow cells re-endothealize injured blood vessel and inhibit neointimal formation. 82
Totale 11.092
Categoria #
all - tutte 62.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 0 0 20
2021/2022588 6 9 26 7 15 23 9 46 45 16 92 294
2022/20232.151 225 155 37 131 207 211 5 116 950 22 55 37
2023/2024953 99 177 33 62 84 270 33 52 6 40 56 41
2024/20252.482 63 173 37 55 79 148 160 162 625 77 312 591
2025/20265.764 498 429 611 580 760 227 1.044 272 616 423 186 118
Totale 14.864